EAGLE, Idaho, July 20, 2017 -- PetIQ, Inc. (“PetIQ” or the “Company”) announced today the pricing of its initial public offering of 6,250,000 shares of the Company’s Class A common stock at a public offering price of $16.00 per share. All of the shares of Class A common stock are being offered by the Company. The shares are expected to begin trading on the Nasdaq Stock Market on July 21, 2017 under the ticker symbol “PETQ.” In addition, PetIQ has granted the underwriters a 30-day option to purchase from PetIQ up to an additional 937,500 shares of its Class A common stock at the initial public offering price, less the underwriting discount and commissions.
The closing of the offering is expected to occur on July 26, 2017, subject to the satisfaction of customary closing conditions.
Jefferies and William Blair are acting as book-running managers for the proposed offering. Oppenheimer & Co, Raymond James, and SunTrust Robinson Humphrey are acting as co-managers.
A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering will be made only by means of a prospectus. A copy of the final prospectus relating to this offering, when available, may be obtained from any of the following sources: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, telephone: (877) 547-6340 or email: [email protected]; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: (800) 621-0687 or email: [email protected]; Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, telephone: (212) 667-8563, or email: [email protected]; Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, telephone: (800) 248-8863, or email: [email protected]; SunTrust Robinson Humphrey, Inc., 303 Peachtree Street, Atlanta, GA 30308, telephone: (800) 685-4786 or email: [email protected].
About PetIQ, Inc.
PetIQ is a pet medication and wellness company bringing a broad portfolio of veterinarian-recommended over-the-counter pet medications to a network of leading national retail stores across the mass, club, grocery, pharmacy, and e-commerce channels. PetIQ’s mission is to deliver pet owners a pipeline of innovative products that combine leading technology with affordability, choice and convenience.
Contacts Media Cory Ziskind ICR 646-277-1232 [email protected] Investors Katie Turner ICR 646-277-1228 [email protected]


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



